Qiuxiang Yin

Title: Innovations and Contributions of Inventor Qiuxiang Yin

Introduction

Qiuxiang Yin is a notable inventor based in Tianjin, China. He has made significant contributions to the field of crystal particle technology, holding a total of six patents. His work focuses on methods that enhance the understanding and application of crystal particles in various industrial contexts.

Latest Patents

One of Qiuxiang Yin's latest patents is titled "Methods for predicting critical caking cycle of crystal particle." This patent provides a method for predicting the critical caking cycle of crystal particles by establishing a CHS crystal bridge growth model database. The method involves selecting existing data based on specific parameters and calculating the critical caking cycle using experience calculation equations. This innovation is characterized by its time-saving, convenience, and high prediction accuracy, which significantly reduces time costs in the storage of industrial crystal particle products.

Another significant patent is "Crystalline form of gamma-aminobutyric acid and preparation method thereof." This patent outlines a method for preparing a new crystalline form of gamma-aminobutyric acid. The process includes preparing a solution, raising the temperature, and filtering to obtain a new crystalline form. This method is noted for being simple, low in energy consumption, and environmentally friendly, making it suitable for large-scale industrial production.

Career Highlights

Qiuxiang Yin has worked with prominent institutions, including Tianjin University and Hainan Lingkang Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in the field of crystal technology and pharmaceuticals.

Collaborations

Some of his notable coworkers include Baohong Hou and Junbo Gong. Their collaborative efforts have likely enhanced the research and development of innovative solutions in their respective fields.

Conclusion

Qiuxiang Yin's contributions to the field of crystal particle technology and pharmaceuticals are noteworthy. His innovative patents demonstrate a commitment to advancing industrial applications and improving efficiency in production processes. His work continues to influence the industry positively.